Insider Transactions in Q1 2024 at Neuroone Medical Technologies Corp (NMTC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.14%
|
$252
$1.2 P/Share
|
|
Mar 31
2024
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.03%
|
$90
$1.2 P/Share
|
|
Mar 31
2024
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-0.19%
|
$2,239
$1.2 P/Share
|
|
Feb 29
2024
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.14%
|
$252
$1.21 P/Share
|
|
Feb 29
2024
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-0.19%
|
$2,239
$1.21 P/Share
|
|
Feb 29
2024
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.03%
|
$90
$1.21 P/Share
|
|
Feb 18
2024
|
Steve Mertens Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,743
+35.55%
|
-
|
|
Feb 18
2024
|
Ronald W. Mc Clurg Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
113,717
+31.78%
|
-
|
|
Feb 18
2024
|
Mark Christianson Business Development Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+7.13%
|
-
|
|
Feb 18
2024
|
David A Rosa CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
663,497
+35.82%
|
-
|
|
Jan 31
2024
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.3%
|
$252
$1.25 P/Share
|
|
Jan 31
2024
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.03%
|
$90
$1.25 P/Share
|
|
Jan 31
2024
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-0.42%
|
$2,239
$1.25 P/Share
|